Navigation Links
Schering-Plough Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV
Date:7/15/2009

nts observed in these patients were generally consistent with expectations for patients with advanced HIV infection and with the multiple drugs being administered.(8)

About Schering-Plough

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.

SCHERING-PLOUGH DISCLOSURE NOTICE: The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the company's clinical development plans and the potential for vicriviroc. Forward-looking statements relate to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough's forward-looking statements, including market forces, economic factors, product availability, patent and other intellectual property protection, current and future branded, generic or over-the-counter competition, the regulatory process, and any developments following regulatory approval, among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough's Securities and Exchang
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting
2. Schering-Plough Announces Results of the Early ACS Trial
3. Schering-Ploughs Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study
4. Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects
5. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
6. Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention
7. Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinsons Disease
8. Schering-Plough Announces European Launch of BRIDION(R) (Sugammadex)
9. Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant
10. About 60 Clinical Studies Regarding Schering-Ploughs Oncology Compounds Will be Presented at ASCO
11. Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) ... District of New Jersey has ... Sandoz, Inc. regarding United Therapeutics, Remodulin ® product.  In ... U.S. Patent No. 6,765,117 is both valid and enforceable ... generic product until the expiration of that patent in ...
(Date:8/29/2014)... , August 29, 2014 ... Market by Product & Services (Equipment, Reagent, Primer, ... Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, ... MarketsandMarkets, the global Oligonucleotide Synthesis Market is expected ... Million in 2014, growing at a CAGR of ...
(Date:8/29/2014)...  Unilife Corporation ("Unilife" or "Company") (NASDAQ: ... to release its financial results for the fiscal 2014 ... market trading ends on Tuesday, September 9, 2014. ... 4:30 p.m. U.S. EDT on Tuesday, September 9, 2014 ... the Company,s financial results, commercial partnerships, and future outlook.  ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2
(Date:9/2/2014)... Squared, a well-known Buy One, Give One company, is ... For every toothbrush purchased, Smile Squared gives one to ... by my wife and me after volunteering at a ... Smile Squared. “There, we saw children who had preventable ... same children didn't own a toothbrush. We wanted to ...
(Date:9/2/2014)... fact that mechanical heart valves increase risks during and ... ROPAC registry presented for the first time today in ... W. Roos-Hesselink, co-chair with Professor Roger Hall of the ... pregnant women with a mechanical heart valve died and ... Of Pregnancy And Cardiac disease (ROPAC) is an ongoing ...
(Date:9/2/2014)... September 02, 2014 Attorney Robert M. ... 2015 "Lawyer of the Year" for Medical Malpractice Law ... Meyer PC, Boston, and has been selected for inclusion in ... one lawyer in each practice area and designated metropolitan area ... particularly impressive voting averages received during the peer-review assessments. ...
(Date:9/2/2014)... 2014 During the fall season, before ... the winter months to prevent costly damage later on. ... company, suggests these fall preventative home maintenance tips. ... frequently throughout fall to prevent build up of leaves ... rot problems, pest infestations, wet basements, foundation damage and ...
(Date:9/1/2014)... web hosting provides a Windows based server environment. There ... and the new demand has resulted in an increase ... a variety of different services at very affordable prices. ... web hosting suppliers from the USA and announced that ... webmasters who want to buy high quality WordPress hosting ...
Breaking Medicine News(10 mins):Health News:Smile Squared's Colorful Buy One, Give One Toothbrush Now Available in Schnucks Stores 2Health News:Mechanical heart valves increase pregnancy risk 2Health News:Mechanical heart valves increase pregnancy risk 3Health News:Robert Higgins Named 2015 Best Lawyers® "Lawyer of the Year" in Boston 2Health News:Northern Virginia Real Estate Company Pasquali Realty Group Suggests These Maintenance Tips for Homeowners This Fall 2Health News:SEO Hosting Review Site Top10BestSEOHosting.com: Best Windows Web Hosting Suppliers From the USA Now Unveiled 2
... lifestyle characteristics can be linked to different invasive breast ... in the open access journal Breast Cancer Research ... the condition are associated with different kinds of tumor. ... California, led a team of researchers who used data ...
... Texas, ophthalmologists recommend ten simple steps to reduce your chance ... More than 20 million Americans suffer from severe vision loss. ... simple steps that everyone can take to help their eyes ... in the future. May is Healthy Vision Month and through ...
... As a health care practitioner, Trina Hammack knew ... ovarian cancer, she knew her prognosis was bleak. ... offering effective new treatments for ovarian cancer. ... of Americans diagnosed with cancer will travel to Mexico ...
... 2009NEW YORK, May 21 New York Blood ... Valley, Brooklyn / Staten Island, and New Jersey are facing ... safe blood supply for hospital patients, including: Number One: ... , Some high school blood drives have been canceled, and ...
... moms linked to higher stress levels in adolescence , , THURSDAY, ... excessive time in child-care facilities or who had insensitive mothers ... a long-term study suggests. , The conclusion is based on ... Development , that by age 15 these children are ...
... gene showed fewer signs of condition , , THURSDAY, May 21 ... allergy-induced asthma has been identified by U.S. researchers, who said ... disease. , The researchers found that mice without the ... "When compared to normal mice, those lacking the gene for ...
Cached Medicine News:Health News:Top 10 Tips to Save Your Vision 2Health News:Top 10 Tips to Save Your Vision 3Health News:Top 10 Tips to Save Your Vision 4Health News:The Diagnosis Every Woman Dreads - Ovarian Cancer 2Health News:The Diagnosis Every Woman Dreads - Ovarian Cancer 3Health News:It's Summer; Patients Need Us to Donate Blood! 2Health News:Teen Stress May Have Roots in First Three Years of Life 2
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Quatroloc Revision Hip System...
Exactech's AcuMatch C-Series (Cemented Femoral Stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
Medicine Products: